Clinical Trials Logo

Clinical Trial Summary

Remimazolam is a novel benzodiazepine with ultra-short onset and offset of its effect. It can be used for general anesthesia. However, classical benzodiazepine such as midazolam was reported to increase the risk of postoperative delirium. Thus, the investigators aim to investigate the effect of remimazolam general anesthesia on postoperative delirium in elderly patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06180876
Study type Interventional
Source Air Force Military Medical University, China
Contact Zhihong Lu
Phone +8613891975018
Email deerlu23@163.com
Status Recruiting
Phase N/A
Start date May 25, 2022
Completion date January 30, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03210077 - Romanian Entropy Clinical Study Network
Completed NCT04851574 - PKPD of Rocuronium and Sugammadex Profile in Pediatric Patients
Recruiting NCT03705728 - Automated Administration of Intravenous Compared With Inhalatory Anesthesia on the Occurrence of Postoperative Delirium N/A
Recruiting NCT02213718 - The Effect of Desflurane on Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting Phase 4
Completed NCT05468671 - Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy Phase 4
Recruiting NCT06216002 - Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery N/A
Recruiting NCT05208502 - Observational of Emergence Time Between Patients Receive General Anesthesia With BIS or Spectrogram EEG Monitor
Completed NCT02617680 - Factors Affecting the Effective End-tidal Concentration of Desflurane Anaesthesia N/A
Recruiting NCT05935930 - Postoperative Effects of Propofol Versus Sevoflurane Anesthesia Phase 4